Cargando…
Considerations of systemic treatment for matrix-producing carcinoma with curative intent
Autores principales: | de Paula, Bruno, Palma dos Reis, Ana Filipa, Crocamo, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547716/ https://www.ncbi.nlm.nih.gov/pubmed/36221274 http://dx.doi.org/10.21037/gs-22-490 |
Ejemplares similares
-
Is it time to retire sentinel lymph node biopsy and use multi-omics prediction models?
por: Kieran, Rosalind, et al.
Publicado: (2022) -
Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023) -
Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
por: Zane, Kylie E, et al.
Publicado: (2022) -
Long-term prognosis and management of hepatocellular carcinoma after curative treatment
por: Nishida, Naoshi
Publicado: (2020) -
Validation of The Hong Kong Liver Cancer Staging System in Patients with Hepatocellular Carcinoma after Curative Intent Treatment
por: Chuncharunee, Alan, et al.
Publicado: (2017)